For its third fiscal quarter (ending September 30), Ligand Pharmaceuticals Inc (NASDAQ: LGND) has reported a -34% decline in E.P.S. from $-0.59 a year ago to $-0.39 in the current quarter. E.P.S. were $2.54 for […]
LSI Industries Inc (NASDAQ: LYTS) has reported earnings for its first fiscal quarter (ending September 30) of $0.23 versus $0.28 for the same period a year ago — a decline of -18%. E.P.S. were $0.80 […]
Insulet Corporation (NASDAQ: PODD) has reported earnings for its third fiscal quarter (ending September 30) of $1.11 versus $0.74 for the same period a year ago — an increase of 50%. For the latest four […]
Inogen Inc (NASDAQ: INGN) has reported E.P.S. of $-0.25 for its third fiscal quarter (ending September 30) versus $-1.97 for the same period a year ago — a decline of -87%. For the latest four […]
Expedia Group Inc (NASDAQ: EXPE) has reported E.P.S. of $5.28 for its third fiscal quarter (ending September 30) versus $2.98 for the same period a year ago — an increase of 77%. For the latest […]
EPAM Systems Inc (NYSE: EPAM) has reported earnings for its third fiscal quarter (ending September 30) of $2.40 versus $1.68 for the same period a year ago — an increase of 43%. For the latest […]
EOG Resources Inc. (NYSE: EOG) has reported E.P.S. of $2.97 for its third fiscal quarter (ending September 30) versus $3.51 for the same period a year ago — a decline of -15%. For the latest […]
Brookdale Senior Living Inc (NYSE: BKD) stock closed at $5.70 on 11/7/24 after a major decline of -11.8%. Moreover, exceptionally high trading volume at 239% of normal accompanied the decline. Relative to the market the […]
Artivion Inc (NYSE: AORT) has reported E.P.S. of $-0.05 for its third fiscal quarter (ending September 30) versus $-0.24 for the same period a year ago — a decline of -79%. For the latest four […]
For its fourth fiscal quarter (ending September 30), Air Products and Chemicals Inc. (NYSE: APD) has reported a 186% increase in E.P.S. from $3.08 a year ago to $8.82 in the current quarter. E.P.S. were […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research